CLL-1 CAR-NK Cells for Relapsed/Refractory AML
Clinical trial NCT06307054 · RECRUITING
Trial details
- NCT number
- NCT06307054
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-03-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.